Rare diseases
Investigational molecules
Locations
Ul. Ziolowa 45/47, 40-635 Katowice, Poland
Gornoslaskie Centrum Mwdyczne in Katowice, Poland specialises in clinical trials of conditions such as Atrial fibrillation, Acute coronary syndrome, Ischaemic stroke, Idiopathic pulmonary fibrosis, and other specialisations. This site conducts important research.
The medical center is at the forefront of cardiology research, particularly in the development of innovative antithrombotic therapies for patients with atrial fibrillation (AF) who have undergone percutaneous coronary intervention (PCI). The center's research focuses on optimizing treatment regimens to enhance patient outcomes and minimize risks.
Through its pioneering studies, the center is contributing significantly to the understanding of how to balance efficacy and safety in antithrombotic therapy, potentially reshaping standard care practices for AF patients post-PCI.
Clinical trials currently enrolling participants at this site.
PolandOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
PolandA Study to Test if Rinvecalinase Alfa is Safe and Works for Treating Acute Ischemic Stroke in Patients with Moderate Stroke Severity
PolandStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
PolandEffect of Ferric Carboxymaltose, Ferrous Sulfate, and Sodium Chloride vs Placebo on Physical Performance in Frail Elderly with Iron Deficiency and Cardiovascular Disease
PolandStudy on JX10 for Improving Outcomes in Patients with Acute Ischemic Stroke
PolandEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
PolandA study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.
PolandA study to evaluate the effectiveness and safety of REGN13335 in adults with pulmonary arterial hypertension
PolandStudy of the efficacy and safety of inclisiran and a drug combination in patients with acute coronary syndrome
PolandA Study of TGD001 in Patients with Acute Ischemic Stroke to Test Safety and Effectiveness
PolandTitle: Evaluating low-dose prednisone with standard therapy to improve heart function in patients with cardiac manifestations of Fabry disease
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
